Open Government Portal
About this information
Open data is defined as structured data that is machine-readable, freely shared, used and built on without restrictions.
The key things to remember about open data are:
- #Availability and access#: the data must be available as a whole and at no more than a reasonable reproduction cost, preferably by downloading over the internet. The data must also be available in a convenient and modifiable form.
- #Re-use and redistribution#: the data must be provided under terms that permit re-use and redistribution including the intermixing with other datasets.
- #Universal participation#: everyone must be able to use, re-use and redistribute. There should be no discrimination against fields of endeavour or against persons or groups. For example, 'non-commercial' restrictions that would prevent 'commercial' use, or restrictions of use for certain purposes (e.g. only in education), are not allowed.
The scope of this risk based interim policy regarding the Clinical Trial requirements is limited to classical FMT (fresh or …
As set out in paragraph C.05.010(b) of the Food and Drug Regulations (FDR), clinical trials must follow certain requirements of …
Pharmacometrics is the science of using quantitative analysis and modelling and simulation (M&S) approaches to inform and enhance drug development …
This Ministerial Order (MO) will give Health Canada an additional 15 days to review all clinical trial applications and amendments …
Drugs intended for use in clinical trials in Canada are regulated under Division 5 of Part C of the Food …
This labelling standard describes the requirements necessary to receive marketing authorization (a Drug Identification Number (DIN)) for oral decongestant non-prescription …
These guidelines will help all persons (individuals and companies) who store and/or transport drugs to comply with Canada’s Food and …
This refers to the situation where a clinical trial is not initiated by a commercial sponsor. In this case, the …
This Notice serves to inform clinical trial sponsors that Health Canada will publish information about all clinical trial applications (CTAs) …
This document is intended to describe the appropriate mechanisms to address drug submission-related disputes.